Sangamo Therapeutics

Home » Sangamo Therapeutics

Secondary

Sangamo Therapeutics

We are a clinical stage biotechnology company focused on translating ground-breaking science into genomic therapies that transform patients’ lives using our industry-leading platform technologies in genome editing, gene therapy, gene regulation and cell therapy.

Symbol

SGMO

Last Closing Price
$16.25

Shares
12,300,000

Anticipated Date
TBD

Underwriters
BofA Merrill Lynch, J.P. Morgan, Cowen

To view the prospectus for Sangamo Therapeutics, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253